Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/01/24 07:05:00 on US and Canada Markets.
- Focus on CLO Investments Expected to Enhance Earnings, Reduce Volatility and Drive Book Value Growth, Utilizing Less Leverage - - Company Revokes REIT Election and Intends to Convert to a Closed End Fund/RIC Later this Year - - Expects to Change Name to Ellington Credit Corporat...
WESTERVILLE, Ohio, April 01, 2024 (GLOBE NEWSWIRE) -- Doodles and Digits and The Scotts Miracle-Gro Foundation announced a partnership to underwrite the television debut of the acclaimed "How It's Math" program on Public Television. Set to premiere this April in celebration of Mathematical Awaren...
New York, New York--(Newsfile Corp. - April 1, 2024) - In response to mounting inflationary pressures in the United States, Birkoa Max Global Macro Fund has demonstrated success with its historical-based investment strategy. Spearheaded by founder and CIO Pranjit Kalita, the company has consisten...
Ramat Gan, Israel--(Newsfile Corp. - April 1, 2024) - Can-Fite BioPharma, Ltd. (NYSE American: CANF) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80 companies presenting in ha...
Nouveau Monde Graphite Inc. (“NMG“ or the “Company”) ( NYSE: NMG , TSX.V: NOU ) announces today the payment of accrued interests as part of a previously announced private placement announced by press release dated November 8, 2022 (the “2022 Private ...
Dillard’s, Inc. (“Dillard’s”) (“the Company”) (NYSE: DDS) is pleased to announce the launch of Caelynn Bell for Gianni Bini, a limited-edition capsule collection designed with nationally known style and travel tastemaker, Caelynn Bell. The collaboration i...
Approval of first-in-class, oral, Factor D inhibitor based on results from pivotal ALPHA Phase III trial VOYDEYA™ (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular hemolysis (EVH) in adults with paroxysmal ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that it will present multiple scientific abstracts at the American Society of Cataract an...
Atlantic Union Bankshares Corporation (“Atlantic Union”) announced today that it has completed its previously announced merger with American National Bankshares Inc. (“American National”), effective April 1, 2024. This transaction strengthens Atlantic Union’s pr...
AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced that it has been selected by the National Aeronautics and Space Administration (NASA) to provide environmental restoration and compliance services at facilities across the United States as part of the NA...